JNJ-64041575
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JNJ-64041575, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations [Phase 1]